SUCHI LAWRENCE: Open Payments
NPI 1720744329 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$750 in 19 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $470 · 2025 $750
Food & beverage: $750
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 8 | $300 |
| AstraZeneca Pharmaceuticals LP | 2 | $135 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $92 |
| HEARTFLOW, INC. | 1 | $76 |
| BridgeBio Pharma, Inc. | 1 | $51 |
| PFIZER INC. | 1 | $33 |
| Kestra Medical Technology Services, Inc. | 1 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $31 |
Products named: CARDIOMEMS, FARXIGA, LifeVest, FFRct, Attruby, WAINUA, VYNDAQEL, Assure WCD.
Industry payments across IL — which companies pay providers there.
